Brandon May

Brandon May is a freelance medical writer and owner of May Medical Communications, LLC. He holds a BS in Nutrition and Dietetics from the University of Houston. Throughout his career, he has written over 700 medical news articles across several different therapeutic areas. In addition to covering the medical news, Brandon also creates content for continuing medical education providers, hospitals, and pharmaceutical and medical device companies across the globe.

All articles by Brandon May

Overweight women being weighed by doctor

Obesity

Obesity, Diabetes and Peripheral Neuropathy in Patients With Class 3 Obesity

Brandon May

February 7, 2022

Peripheral neuropathy may be influenced by obesity and dyslipidemia. Researchers sought to examine this relationship.

Bone Metabolism

Dried Plum Consumption May Offer Modest Bone Health Benefit in Men

Brandon May

February 4, 2022

Bone health can sometimes be improved by the use of certain supplements and dietary changes. Researchers studied whether dried plums would have a beneficial effect in men.

Cardiovascular and Metabolic Disorders

High Blood Pressure, BMI Tied to Greater Burden of Cerebral Small Vessel Disease

Brandon May

January 26, 2022

Using Mendelian randomization, researchers investigated which cardiovascular risk factors are likely to be implicated in the etiology of cerebral small vessel disease.

Cardiovascular and Metabolic Disorders

Comorbid Insomnia, Sleep Apnea and the Risk for All-Cause Mortality and CVD

Brandon May

January 19, 2022

What is the combined effect of insomnia and OSA on all-cause mortality and the occurrence of hypertension, cardiovascular disease, and diabetes?

Cardiovascular and Metabolic Disorders

Remnant Lipoprotein Cholesterol May Predict Fatty Liver Disease Risk

Brandon May

January 10, 2022

The role certain blood lipid components have in the development of fatty liver disease (FLD) has been hypothesized but not confirmed. Researchers studied whether there was a correlation between remnant lipoprotein cholesterol (RLP-C) and occurrence of FLD.

Obesity

Obesity Mediates Diabetes Risk Associated With Cholesterol-Lowering Therapy

Brandon May

January 6, 2022

Increased type 2 diabetes risk has been observed with cholesterol-lowering drugs and may be mediated by increased body mass index. Investigators examined the link.

We review the role of a new class of agents in improving glycemic control and reducing diabetes-related vascular disease.

Type 1 Diabetes

Glycemic Control in Type 1 Diabetes and Use of Multiple Daily Injections

Brandon May

January 4, 2022

Glycemic control in people with type 1 diabetes is challenging. Researchers investigated whether a continuous glucose monitoring-based decision support system could help.

Type 2 Diabetes

Switch From Rapid-Acting to Concentrated Insulin Improves Glycemic Control

Brandon May

December 30, 2021

Insulin delivered by continuous subcutaneous insulin infusion is often effective in people with type 2 diabetes vs multiple daily injections, but many still do not reach glycemic targets. Investigators sough the reason behind this challenge.

Type 1 Diabetes

Fear of the Unknown: Q&A With A Pediatric Diabetes Psychologist

Brandon May

December 22, 2021

Children with type 1 diabetes require complex care, which can be stressful for them and their parents. Endocrinology Advisor spoke with pediatric psychologist Cynthia E. Munoz, PhD, MPH, about the challenges these parents face.

Obesity

Bariatric Surgery May Reduce Cancer Risk in Obesity and Type 2 Diabetes

Brandon May

December 22, 2021

Liver, esophageal, endometrial and other cancers are associated with type 2 diabetes and obesity. Researchers studied whether bariatric surgery could reduce these cancer risks.

Next post in Obesity